INTRODUCTION {#sec1-1}
============

Dendritic cells (DCs) were first described in the mid-1970s by Ralph Steinman, who observed in the spleen a subpopulation of cells with a striking dendritic shape and as potent stimulators of primary immune response. They patrol all tissues of the body with the possible exceptions of the brain and testes. During the 1970s, most immunologists considered macrophages to be the principal antigen-presenting cell (APC) in the immune system. Compared to DCs, macrophages were more abundant, were uniformly distributed throughout the body, and were known to have antigen-presenting capabilities. Since DCs are so rare, initial studies were difficult, and it was not until the 1980s that it became widely accepted that DCs were "Professional" APCs.\[[@ref1]\]

While the rarity of DCs was a hindrance to studying them, in the 1990\'s, researchers learned how to generate large numbers of DCs from CD34^+^ bone marrow precursors or from CD14^+^ monocytes *in vitro*. The ability to expand functional DCs *in vitro* has increased researchers' ability to study DCs to understand mechanisms of DC interactions with the immune system and to begin to test DC therapy regiments in the clinic.\[[@ref2]\]

In the peripheral tissues of humans, three major DC subsets have been described including two in the myeloid lineage-Langerhans cells and interstitial DC (also known as dermal DC) and the third being lymphoid or plasmacytoid DC.\[[@ref3]\]

DENDRITIC CELLS IN PERIODONTICS {#sec1-2}
===============================

A lot of evidence has accumulated that supported the role of dentridic cells (DCs) in maintenance of oral health and possibly, in the pathogenesis of oral diseases.\[[@ref4]\] Most of these studies identified CD1a^+^ Langerhan cells (LCs) rather than other DC subsets. In regard to gingivitis and periodontitis, LCs increased in number in the epithelium with gingivitis, experimental gingivitis, and periodontitis.\[[@ref5]\]

AGGRESSIVE PERIODONTITIS {#sec1-3}
========================

The potential role of DCs in aggressive periodontitis (AP) has also been analyzed *in vitro*. *Aggregatibacter actinomycetemcomitans (Aa)*, an etiological agent in localized aggressive periodontitis (LAP), appears to activate/mature DCs and induce a Th1-response. *In vitro* modeling has led to the hypothesis of a novel mechanism for how DCs may promote elevated IgG2 responses observed in patients with LAP.\[[@ref6]\]

The monocytes (M) of localized juvenile periodontitis (LJP) and non-periodontitis (NP) patients mature into both macrophage (MØ) and monocyte-derived dendritic cells (MDDC), but the percentage of MDDC is more in case of LJP. The LJP monocytes secrete cytokines \[Platelet-activating factor (PAF) and PGE~2~\] that selectively promote the production of IgG~2.~ MDDC synthesize PGE~2~ in response to nanomolar concentrations of PAF while MØ makes no comparable response. Although M and MØ synthesize PAF, M accumulates more PAF than MØ; this is because when M is skewed towards MØ, there is increased activity of platelet-activating factor acetyl hydrolase (PAFAH), which decreases the level of PAF produced by MØ. The M-derived PAF acts on MDDC and leads to production of IgG~2~ (protective response) and PGE~2~ (causes localized destruction). Thus, the MDDC that arise from LJP monocytes promote the production of a subclass of antibody that is uniquely suited to facilitate the immune response against oral pathogens\[[@ref7][@ref8]\] \[[Figure 1](#F1){ref-type="fig"}\].
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Together, it is likely that the clinical impact of the MDDC is a balance between the destructive effects of inflammation and the protective effects of IgG2. A clearer understanding of the maintenance of this balance and the factors that affect it may lead to more effective treatments for severe periodontal diseases like LJP.\[[@ref7]\]

CHRONIC PERIODONTITIS {#sec1-4}
=====================

LCs in the gingival epithelium are very responsive to the accumulation of bacterial plaque, migrating into the site during early gingivitis, and migrating out as the gingivitis becomes more chronic (i.e., after 21 days).\[[@ref6]\] Another study reports, LCs decrease in epithelium with gingivitis and periodontitis.\[[@ref9]\] This disparity is likely, due to a number of variables, including the quality of the tissue samples, the method of histophometry, the area of the gingiva being analyzed (pocket, junctional, oral, sulcular epithelia), and the 'time window' of sampling. Their increased presence in epithelium from healthy to gingivitis to periodontitis is evidenced by presence of transforming growth factor- β (TGF-β), which is required for the development of LCs *in vivo* and from monocytes *in vitro* in a higher level in the milieu of chronic periodontitis (CP). If LCs are indeed emigrating, they are being renewed by precursors continuously immigrating. One *in vitro* study presents the intriguing possibility that local monocytes might be the LC-precursor. These activated LCs enters lamina propria and ultimately end up in lymph nodes.\[[@ref10]\]

ORAL LYMPHOID FOCI (OLF) WITHIN INTERDENTAL PAPILLA {#sec1-5}
===================================================

It is suggested that the mature DCs play a role in formation of so-called 'Oral lymphoid follicles' or lymphoid foci that develop interproximally around the teeth in periodontitis, and this is initiated in gingivitis by LCs or their progenitors homing to the epithelium in response to pathogen-associated molecular patterns (PAMP) in the oral biofilm. The LCs migration out of the epithelium may also be in response to cytokine signals for lymphoid/myeloid trafficking, i.e. epithelium/keratinocytes. These immature DCs migrate out of the gingival/pocket epithelium during chronic gingivitis, undergoing maturation as they traffic to the lymph nodes, where a T cell response is elicited \[[Figure 2](#F2){ref-type="fig"}\]. This model postulates that the formation of OLF is dependent on mature DCs becoming 'stalled' within gingival lamina propria, and then these mature DCs elicit a recall T cell response locally. This implies that the OLFs are not fully developed unless and until sufficient antigenic challenge is provided by specific PAMP of pathogen/commensals in the sub-gingival flora like *P. gingivalis* (Pg) and *F. nucleatum*. To summarize, the presence of mature DCs represent that there is presence of OLF in interdental papilla. However, the presence of germinal centers, as observed in lymphoid follicles, has not yet been identified in OLF.\[[@ref3][@ref11]\]
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DENDRITIC CELLS IN LINKING INNATE AND ACQUIRED IMMUNITY {#sec1-6}
=======================================================

In 1992, Polly Matzinger proposed that it was the innate immune system that recognized danger and delivered non-specific signals to specific T and B cells, stimulating them as to clonally divide and differentiate into effector lymphocytes and antibody-secreting cells, respectively. Thus, the older idea that the immune system learns a complicated set of rules early in ontogeny about how to recognize self and respond only to "not self" was exchanged for a simpler model. The newer model is that professional APCs respond to the environment and carry an antigenic message to responder cells to instruct them to either develop tolerance or productive immunity.\[[@ref12][@ref13]\]

A critical indirect role for DCs in B cell stimulation relate to their role in activating T cells to up-regulate CD40L and secrete B cell helper factors. However, interdigitating DCs within the paracortical areas of the lymph node can interact directly with CD40-activated naive B cells to induce proliferation through an unidentified mechanism. Furthermore, in an IL-12- dependent mechanism, DCs contribute to B cell differentiation into IgM-secreting plasma cells\[[@ref14]\] \[[Figure 3](#F3){ref-type="fig"}\].
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The interaction of T cell area DCs with B cells may be facilitated by Ebstein-Barr virus-induced molecule-1 ligand chemokine (ELC) secretion, which attracts activated B cells as well as naive T cells to the DCs microenvironment.\[[@ref15]\] When DCs mature, they are unable to secrete polarizing cytokines such as IL-12 and undergo senescence, limiting the time frame, within which they could stimulate immunity. In summary, DCs link innate and adaptive immunity by receiving danger signals that render them capable of maturing and inducing productive immunity rather than tolerance.\[[@ref2]\]

Also, the link between innate and adaptive immunity is explained by the fact that DCs produce IL-2. It is believed that IL-2 was exclusively produced by T cells; this made it difficult to explain how natural killer cells, part of the innate immune system, become exposed to IL-2 prior to activation of the adaptive immune response. Since DCs are capable of producing IL-2 after activation by bacteria, this IL-2 acts on natural killer cells before the IL-2, which is produced by T cell. This explains DCs role in linking innate and adaptive system\[[@ref3]\] \[[Figure 4](#F4){ref-type="fig"}\].
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IMMUNE SUPPRESION/TOLERANCE {#sec1-7}
===========================

Failure of migrating DCs to mature en route to the lymph nodes or the ability of DCs to depolarize cytokine profiles can lead to immune suppression/tolerance i.e., towards commensals or self-antigens. Pg lipopolysaccharide (LPS) may promote immunosuppression by this route, inducing weak DC maturation and a Th~2~ bias, which is anti-inflammatory \[[Figure 2](#F2){ref-type="fig"}\]. Moreover, certain Pg LPS moieties suppress DC maturation by LPS from other species. This suggests that Pg may be the proverbial 'Wolf in sheep\'s clothing' -- appearing to the host as a commensal organism, while invading host tissue and suppressing the immune response towards other species. This characteristic of Pg is consistent with the presentation of periodontitis: Long-standing, low-grade inflammation that is difficult to resolve. Resolution of inflammation is generally favored by migration of fully matured DCs from inflamed sites into lymph nodes, where a Th~1~ (inflammatory) type cell-mediated immune response can be induced.\[[@ref11]\]

The differential localization of DC subpopulations in gingival mucosa, with immature CD1a^+^ localized to the epithelium in health and disease and mature CD83^+^ DCs restricted to the T cell-rich lamina propria (LP) in CP, has been demonstrated. The presence of elevated levels of cytokines IL-1β, PGE2, and IL-10 in the local milieu of active CP suggests a counter-regulatory microenvironment supportive of DC maturation, but inhibitory of an effective cell-mediated response. *In vitro* evidence indicates that Pg and its LPS induce DCs to mature (through IL-1β, PGE2., etc.) but stimulate the release of counter-regulatory cytokines through IL-10 (as *in vivo*) and promotes an inefficient T cell response.\[[@ref5]\]

ROLE IN CHRONIC SYSTEMIC INFLAMMATION {#sec1-8}
=====================================

Periodontitis appears to promote chronic inflammatory diseases, including atherosclerosis, but relevant mechanisms need clarification. Oral bacteria like Pg and Aa induce remarkable IgG responses from the host that are dominated by IgG2, and IgG2 is IFN-γ-dependent and is promoted by dendritic cells (DCs). IgG2 binds not only bacteria but also oxidized LDL (oxLDL) and thus form immune complexes. LDL-reactive antibodies induced by Pg and Aa include anti-phosphorylcholine (α-PC) and β2-glycoprotein-1-dependent anti-cardiolipin (α-CL), and these antibodies may link chronic inflammatory diseases at a mechanistic level\[[@ref16]\] \[[Figure 5](#F5){ref-type="fig"}\].
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Normal human sera contain α-PC antibodies.\[[@ref17]\] These antibodies are primarily in the IgG2 and IgG1 subclasses and recognize both bacterial PC as well as many self-antigens, which contain PC, including platelet-activating factor (PAF), apoptotic cells, and oxLDL.\[[@ref18]\] PC-bearing strains of Aa are capable of invading human endothelial cells via the PAF receptor, demonstrating a potential route of access to the systemic circulation for oral-bacteria-bearing PC.\[[@ref19]\]

Anti-cardiolipin (α-CL) antibodies are characteristically found in sera of patients with anti-phospholipid syndrome (APS) and systemic lupus erythematosis. The major target antigen of autoimmune α-CL is a β2-glycoprotein-1 (β2GPI).\[[@ref1]\] The pathogenicity of α-CL is thought to be related to its ability to interfere with the regulatory function of β2GPI in prevention of the initiation of coagulation.\[[@ref20]\]

It has been proposed that infection with a variety of viral and bacterial pathogens can induce pathogenic α-CL via molecular mimicry.\[[@ref21]\] These IgG antibodies bind PC or TLRVYK on oxLDL and TLRVYK-like sequences on Aa and Pg. These interactions result in ICs that bind activating-Fc receptors on DCs and promote engulfment of the ICs, antigen processing, and production of the IL-12 and IL-18 that promotes early-IFN-γ production by NK cells and later by T cells in inflamed sites. Numerous pro-inflammatory chemokines and cytokines are produced by stimulated T cells and macrophages that promote atherosclerosis. Production of pro-inflammatory cytokines by macrophages is well-known, although IFN-γ production is controversial\[[@ref16]\] \[[Figure 5](#F5){ref-type="fig"}\]. Proinflammatory cytokines and chemokines may up-regulate adhesion molecules on the epithelium and help sustain the influx of macrophages and other inflammatory cells. Macrophages activated by IFN-γ may promote plaque destabilization.\[[@ref22]\] Disruption of atherosclerotic plaque and thrombus formation may result in embolization that may cause myocardial infarction, stroke, or peripheral arterial occlusive disease. Thus, engagement of DCs in the sub-endothelial layer of arterial walls with α-PC/α-CL bound to microorganisms, microbial products, or oxLDL from the blood may trigger a pathway in atheromas involving DC-IL-12 production, antigen presentation, IFN-γ production, macrophage activation, plaque disruption, embolization, and, ultimately, life-threatening disease.\[[@ref16]\]
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Thus, to summarize, the Aa and Pg-induced antibodies can bind both oxLDL and oral bacteria and participate in DC-dependent mechanisms that promote inflammation. Elevated soluble-intercellular adhesion molecules are atherosclerosis-associated indicators of vascular inflammation, and these markers are elevated in AgP individuals with high α-CL. Thus, the subset of individuals with periodontitis with elevated α-CL levels may be at high risk of atherosclerosis and/or adverse pregnancy outcomes. Fortunately, serum α-PC and α-CL levels can be determined with simple blood tests, and individuals with high antibody levels may be assisted by reducing cholesterol levels to minimize atherosclerosis risk and by prenatal care to minimize adverse pregnancy outcomes.\[[@ref16]\]

PLASTICITY AND ROLE IN OSTEOIMMUNOLGY {#sec1-9}
=====================================

A new emerging field of research, termed osteoimmunology by Arron and Choi, deals with the role of the immune system in bone remodeling. In this context, many DC subtypes can be found in the joints of patients with rheumatoid arthritis (RA) and may contribute to the exacerbated osteoclastogenesis. Santiago-Schwarz *et al*. have recently suggested that the inflamed RA joint controls DC growth and may be a reservoir for DC amplification and the perpetuation of DC-driven inflammatory responses. They proposed that DC contribution to osteoclastogenesis is only indirect and linked to their ability to activate naive T cells, which then produce receptor activator of NF-Kβ Ligand (RANKL) and stimulate osteoclast (OC) differentiation.\[[@ref23]\]

Recently, a study was conducted to find the direct role of DC in osteoclast differentiation. The study demonstrates that upon proper activation by microbial or protein antigens (namely Aa, bovine insulin, and outer membrane protein-1) and during immune interactions with CD4^+^ T cells *in vitro*, DC can indeed act like OC precursors. In addition, these DC-derived OC are capable of inducing bone loss after adoptive transfer *in vivo*. These data suggest a direct contribution of DC during immune interactions with CD4^+^ T cells to inflammation-induced osteoclastogenesis \[[Figure 6](#F6){ref-type="fig"}\]. These findings not only provide further evidence for DC plasticity, but also extend the current paradigm of osteoimmunology.\[[@ref24]\]

FATE OF DENDRITIC CELLS {#sec1-10}
=======================

Antigen-bearing DCs are in direct contact with naive antigen-specific T cells within the T cell areas of lymph nodes, and after interaction with T cells, these DCs are rapidly eliminated. For DC elimination to occur, activated T cells induce apoptosis of DCs by producing the TNF family molecules. The relevance of DC death after antigen presentation could be shown in patients with autoimmune lymphoproliferative syndrome (ALPS). This indicates that mature DCs presenting antigens to T cells have to be effectively eliminated in order to avoid excessive immune responses. The life span of DCs might thus be an important checkpoint to control for the induction of tolerance, priming, and chronic inflammation.\[[@ref25]\]

FUTURE DIRECTIONS {#sec1-11}
=================

A study done by Granucci *et al*. used microarray technology representing 11,000 genes and expressed sequence tags (ESTs) to identify the genes that are differentially expressed upon exposure of murine DC or MØ to gram-negative bacteria (i.e. *E. coli*). Approximately 3,000 differentially expressed transcripts were identified, some of which conferred DC with a high T cell-stimulatory capacity relative to MØ.\[[@ref26]\]

Although these studies used 'generic' stimulants, they provided the groundwork for more disease and pathogen-specific analysis of DC. In periodontitis, for e.g. it would be extremely important to analyze the genes on DCs (or other cells that are in direct contact with the biofilm such as epithelial cells) that are turned on or off by exposure to PAMP of the oral biofilm and associated gingival health vs. disease.\[[@ref3]\]

The capacity of LCs and CD14^+^ DCs to preferentially prime cellular immunity and humoral immunity, respectively, has significant implications, most particularly in the context of novel human vaccines. Vaccines like Polio, Measles, Hepatitis B are all specific for acute infections, and their protective capacity arises largely from their induction of humoral immune responses. They principally deliver antigen to and activate CD14^+^ DCs but not LCs. Therefore, targeting LCs will be important for the design of vaccines that aim at eliciting strong cellular immunity. Such vaccines might be particularly useful at preventing, and perhaps even treating chronic diseases (Periodontitis) and cancer.\[[@ref27][@ref28]\] Therefore, most efficient vaccines might actually be those that will target both CD14^+^ DCs and LCs, thereby allowing the maximal stimulation of both humoral and cellular immune responses \[e.g., Smallpox, Yellow fever vaccine\].\[[@ref29]\]

Recently, in an unpublished datum, it is stated that HA2 domain-based periodontitis vaccine was developed by Arthur Decarlo, and the results showed good immune response to HA2 immunotherapy, minimized development of periodontal disease, and was safe in animal models.\[[@ref30]\]

CONCLUSION {#sec1-12}
==========

The treatment for periodontitis is emphasized more on anti-microbial, mechanical, and surgical/regenerative approaches. Even though generally effective, these treatments are generally applied after the 'damage has been done.' It would seem prudent to develop pharmacotherapeutic agents that function 'upstream' of the events that destroy the supporting tissues of the dentition. As antigen presentation through DC is the rate-limiting step in the generation of the immune/inflammatory response, blocking specific aspects of antigen presentation or the events that precede it may be a valid strategy for upstream control of periodontitis.
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